Response of folliculotropic mycosis fungoides to capecitabine
J Dtsch Dermatol Ges
.
2023 Jul;21(7):792-794.
doi: 10.1111/ddg.15066.
Epub 2023 Apr 25.
Authors
Angela Estenaga
1
,
Luisa Sanchez-Lorenzo
2
,
Javier Antoñanzas-Pérez
1
,
Ana Morelló-Vicente
1
,
Inés Oteiza-Rius
1
,
Carolina Arean Cuns
3
,
Jillian Wells
4
5
,
Francisco Javier García-Martínez
6
Affiliations
1
Dermatology Department, Clínica Universidad de Navarra, Pamplona, Spain.
2
Medical Oncology Department, Clínica Universidad de Navarra, Madrid, Spain.
3
Pathology Department, Clínica Universidad de Navarra, Madrid, Spain.
4
Department of Dermatology, Westmead Hospital, Sydney, NSW, Australia.
5
Faculty of Medicine, Sydney University, Sydney, NSW, Australia.
6
Dermatology Department, Clínica Universidad de Navarra, Madrid, Spain.
PMID:
37186164
DOI:
10.1111/ddg.15066
No abstract available
Keywords:
capecitabine; chemotherapy; fluoropyrimidines; mycosis fungoides; sonography.
Publication types
Letter
MeSH terms
Capecitabine / therapeutic use
Humans
Mycosis Fungoides* / drug therapy
Skin Neoplasms* / drug therapy
Substances
Capecitabine